Abstract
Background Endovascular treatment (EVT) of acute ischemic stroke can be complicated by vessel perforation. We studied the incidence and determinants of vessel perforations. In addition, we studied the association of vessel perforations with functional outcome, and the association between location of perforation on DSA and functional outcome, using a large EVT registry.
Methods We included all patients in the MR CLEAN Registry who underwent EVT. We used digital subtraction angiography (DSA) to determine whether EVT was complicated by a vessel perforation. We analyzed the association with baseline clinical and interventional parameters using logistic regression models. Functional outcome was measured using the modified Rankin Scale (mRS) at 90 days. The association between vessel perforation and angiographic imaging features and functional outcome was studied using ordinal logistic regression models adjusted for prognostic parameters. These associations were expressed as adjusted common odds ratios (acOR).
Results Vessel perforation occurred in 74 (2.6%) of 2794 patients who underwent EVT. Female sex (aOR 1.9 [95%CI 1.2-3.1]) and distal occlusion locations (aOR 2.2 [95%CI 1.4-3.7]) were associated with increased risk of vessel perforation. Functional outcome was worse in patients with vessel perforation (acOR 0.41, 95%CI 0.25-0.68) compared to patients without a vessel perforation. No significant association was found between location of perforation or successful reperfusion and functional outcome.
Conclusion The incidence of vessel perforation during EVT is low, but it has severe clinical consequences. Females and patients with a distal occlusion locations are at higher risk. The location of vessel perforation or successful reperfusion did not affect functional outcome.
Competing Interest Statement
Erasmus MC received funds from Stryker® by DD, AvdL, and Bracco Imaging® by DD. Amsterdam UMC received funds from Stryker® for consultations by CM, YR and OB. MUMC received funds from Stryker® and Codman® for consultations by WZ.
Funding Statement
The MR C LEAN Registry was partly funded by TWIN Foundation, Erasmus MC University Medical Center, Maastricht University Medical Center, and Amsterdam UMC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The central medical ethics committee of the Erasmus MC University Medical Center evaluated the MR CLEAN Registry study protocol, granted permission to carry out the study as a registry (MEC-2014-235)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data is available through the data-request procedure of MR CLEAN trial office. Contact: Naziha el Ghannouti, research coordinator Erasmus MC University Medical Center Ee 2234 PO BOX 2040 3000 CA Rotterdam The Netherlands Tel: +31 10 704 3818 Fax: +31 10 704 4721 mrclean{at}erasmusmc.nl
Nonstandard Abbreviations and Acronyms
- A1-A2-A3
- – segment of anterior cerebral artery
- DSA
- – Digital Subtraction Angiography
- EVT
- – Endovascular thrombectomy
- eTICI
- – extended Treatment In Cerebral Ischemia score
- ICA
- – internal carotid artery
- IVT
- – intravenous thrombolysis
- M1-M2-M3
- – M1-M2-M3 segment of middle cerebral artery
- mRS
- – modified Rankin Scale
- NIHSS
- – National Institutes of Health Stroke Scale
